½É¹æ ¼¼µ¿ ȯÀÚ¿¡°Ô propafenone Åõ¿© ÈÄ ¹ßÇöµÈ Brugada ½ÉÀüµµ ÆÐÅÏ 1¿¹
A Concealed Brugada Electrocardiogram Pattern Revealed after Administering Propafenone to a Patient with Atrial Fibrillation
´ëÇѳ»°úÇÐȸÁö 2014³â 86±Ç 1È£ p.70 ~ p.73
½ÉÇüÈÆ(Sim Hyoung-Hun) - ±¹¸³°æÂûº´¿ø ³»°ú
±Ç³«Çö(Kwon Nak-Hyun) - ±¹¸³°æÂûº´¿ø ³»°ú
¹éÁÖ¿µ(Baeg Joo-Yeong) - ±¹¸³°æÂûº´¿ø ³»°ú
À±Ã¢¿ë(Yun Chang-Yong) - ±¹¸³°æÂûº´¿ø ³»°ú
¾È¼ö¹Î(Ahn Soo-Min) - ±¹¸³°æÂûº´¿ø ³»°ú
¿ÀÀ¯¹Ì(Oh Yu-Mi) - ±¹¸³°æÂûº´¿ø ³»°ú
±è¿µÁß(Kim Young-Jung) - ±¹¸³°æÂûº´¿ø ³»°ú
Abstract
Brugada syndrome is characterized by sudden cardiac death associated with ventricular tachyarrhythmia in patients without structural heart disease. We recently observed a case of concealed Brugada ECG pattern, which appeared after oral propafenone administration for atrial fibrillation. A 34-year-old male patient who experienced syncope was admitted to the emergency department with acute atrial fibrillation (AF). Three hundred milligrams of propafenone that were administered to convert AF to sinus rhythm unmasked the Brugada ECG pattern that had remained concealed. The patient showed a type 1 Brugada ECG pattern after taking propafenone.
Å°¿öµå
Brugada syndrome, Atrial fibrillation, Propafenone
KMID :
0882420140860010070
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)